753688
Last Update Posted: 2013-08-22
Recruiting has ended
All Genders accepted | 18 Years + |
369 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy
Eligibility
Relevant conditions:
Sarcoma, Soft Tissue
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov